...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Gene expression profiling for the identification of G-protein coupled receptors in human platelets.
【24h】

Gene expression profiling for the identification of G-protein coupled receptors in human platelets.

机译:用于鉴定人血小板中G蛋白偶联受体的基因表达谱。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION AND MATERIALS AND METHODS: G-protein coupled receptors (GPCRs) play an important role in platelet aggregation. To identify new platelet GPCRs, a platelet gene expression profile was generated and validated using quantitative real-time PCR. RESULTS: In total, mRNA of 28 GPCR genes was detected in human platelets. The 12 most abundant platelet GPCR transcripts were: thrombin receptor PAR1 (1865+/-178%), ADP receptor P2Y(12) (459+/-88%), succinate receptor 1 (257+/-48%), ADP receptor P2Y(1) (100%), orphan P2RY(10) (68.2+/-3.3%), lysophosphatidic acid receptors GPR23 (48.2+/-11%) and GPR92 (26.1+/-3.3%), adrenergic receptor alpha(2A) (18.4+/-4.4%), orphan EBI2 (6.31+/-0.42), adenosine receptors A(2A) (2.94+/-0.24%) and A(2B) (2.88+/-0.16%) and lysophosphatidic acid receptor LPA(1) (2.59+/-0.39%) (% relative to the chosen calibrator P2Y(1)). A surprising G-protein coupled receptor redundancy was found: two ADP receptors (P2Y(1) and P2Y(12)), three adenosine receptors (A(2A), A(2B), and A(1)), four lysophosphatidic acid receptors (LPA(1), LPA(3), GPR23 and GPR92), two l-glutamate receptors (mGlu(3) and mGlu(4)) and two serotonin receptors (5-HT(1F) and 5-HT(4)). The adenosine receptor A(2B) gene expression was validated with protein expression and functional studies. Western blot confirmed A(2B) receptor protein expression and platelet flow cytometry demonstrated inhibition of the effect of NECA by the adenosine A(2B)-antagonist MRS1754. CONCLUSIONS: We have detected several GPCRs not previously known to be expressed in platelets, including a functional adenosine A(2B) receptor. The findings could improve our understanding of platelet aggregation and provide new targets for drug development.
机译:简介和材料与方法:G蛋白偶联受体(GPCR)在血小板聚集中起重要作用。为了鉴定新的血小板GPCR,产生了血小板基因表达谱,并使用定量实时PCR进行了验证。结果:在人体血小板中共检测到28个GPCR基因的mRNA。 12种最丰富的血小板GPCR转录物是:凝血酶受体PAR1(1865 +/- 178%),ADP受体P2Y(12)(459 +/- 88%),琥珀酸受体1(257 +/- 48%),ADP受体P2Y(1)(100%),孤儿P2RY(10)(68.2 +/- 3.3%),溶血磷脂酸受体GPR23(48.2 +/- 11%)和GPR92(26.1 +/- 3.3%),肾上腺素能受体α( 2A)(18.4 +/- 4.4%),孤儿EBI2(6.31 +/- 0.42),腺苷受体A(2A)(2.94 +/- 0.24%)和A(2B)(2.88 +/- 0.16%)和溶血磷脂酸受体LPA(1)(2.59 +/- 0.39%)(相对于所选校准品P2Y(1)的百分比)。发现了令人惊讶的G蛋白偶联受体冗余:两个ADP受体(P2Y(1)和P2Y(12)),三个腺苷受体(A(2A),A(2B)和A(1)),四个溶血磷脂酸受体(LPA(1),LPA(3),GPR23和GPR92),两个l-谷氨酸受体(mGlu(3)和mGlu(4))和两个血清素受体(5-HT(1F)和5-HT(4 ))。腺苷受体A(2B)基因表达已通过蛋白质表达和功能研究验证。 Western印迹证实A(2B)受体蛋白的表达和血小板流式细胞仪证明腺苷A(2B)-拮抗剂MRS1754对NECA的抑制作用。结论:我们检测到了几种以前未知在血小板中表达的GPCR,包括功能性腺苷A(2B)受体。这些发现可以增进我们对血小板聚集的理解,并为药物开发提供新的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号